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Autistic disorder, Asperger syndrome, and PDD-Not Otherwise Specified 
are subsets of autism spectrum disorders (ASDs), which are characterized by 
impairments in social communication and stereotyped behavior. This article 
reviews the prevalence, etiology, diagnosis, and treatment of ASDs in Iran.
Materials & Methods
We searched PubMed, ISI Web of Science, and 4 Iranian databases (IranPsych, 
IranMedex, Irandoc and Scientific Information Database (SID) to find Iranian 
studies on ASDs. The results of 39 investigations, comprising original, review 
and editorial articles; proceedings; and available dissertations were categorized 
by prevalence, etiology, diagnosis, and treatment. 
Conclusion
Several preliminary investigations have been done to evaluate the prevalence 
of ASDs, and risk factors and effective variables have been studied with regard 
to etiology. The diagnostic evaluation of ASDs, especially based on EEG, and 
several pharmacological and behavioral interventions for ASD have been 
implemented in Iran. Mental health, stress levels, and personality characteristics 
were examined in the parents of children with ASDs, which were focused on 
mothers. 
Keywords: Autism spectrum disorders (ASDs); prevalence; etiology; diagnosis; 
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Introduction
Pervasive Developmental Disorders (PDD) is severe developmental abnormalities 
in many fundamental psychological functions that are characterized by persistent 
social impairment, speech disorders, and exotic motor movements. Autism Spectrum 
Disorders (ASDs), which is one of the PDD and includes autistic disorder, Asperger 
syndrome and PDD not otherwise specified, are characterized by abnormalities in 
social interaction, verbal and non verbal communications and having repetitive 
and stereotyped behaviors (1, 2, 3). ASDs have multiple etiologies, from genetic to 
environmental factors (4, 5).
Less attention has been paid to the study of ASDs especially their epidemiology in 
developing countries. In fact, most studies on ASD prevalence have been performed 
in the United States and Europe (6). Totally, recent scientific researches indicated that 
the rates of ASDs are rising. In primary school children, the rate estimated of ASD 
prevalence is 157 per 10,000 children in the United Kingdom (7). The only study on 
adults with ASDs calculated a prevalence of 98 per 10,000 in England (8). A study 
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on 8 years old children with ASDs estimated that 90 per 
10,000 participants were affected in the United States 
(9). In a comprehensive review, the prevalence rate was 
approximately 20 per 10,000 for autistic disorder, 30 per 
10,000 for PDD-NOS, and 2 per 100,000 for Asperger 
syndrome (10). In contrast, the rates of Asperger 
syndrome are 36 and 48 per 10,000 children in Sweden 
(11, 12).
ASD prevalence rates vary across the world. Accordingly, 
these differences are related to the age of participants, 
diagnostic criteria, and the geographical locations. Also, 
lower prevalence rates of ASDs in developing countries 
can be explained by the scarcity in services and the lack
of awareness about ASD (13).
Because cultural factors play an essential role in the 
prevalence, diagnosis, and treatment of ASDs, they 
should be examined (14). Thus, research on ASDs in 
Iran will be reviewed in this article.
 
Materials & Methods 
A systematic literature review was performed to identify 
ASD studies in Iran. Accordingly, PubMed, ISI Web of 
Science, and 4 Iranian databases (IranPsych, IranMedex, 
Irandoc, and Scientific Information Database (SID) 
were searched to find Iranian studies on ASDs using 
a combination of 2 groups of terms. The first group 
included the terms: autism spectrum disorders, autism, 
autistic disorder, PDD-Not Otherwise Specified, and 
Asperger, combined with OR; the second group consisted 
of Iran or its major cities. The names of famous Iranian 
researchers in the ASD field and their curriculum vitae 
were also searched to find scientific studies on ASDs 
in Iran. Case reports were excluded; the results of 39 
investigations, including original, review, and editorial 
articles; proceedings; and available dissertations were 
categorized based on prevalence, etiology, diagnosis, 
and treatment. 
Literature Review
There are epidemiological and clinical studies about the 
frequency, etiology, diagnosis, and treatment of ASDs in 
Iran. 
Prevalence of ASDs 
While there is no advanced study on ASD prevalence 
in Iran (15), Ghanizadeh`s preliminary investigation in 
school children (2008) indicated a rate of 19 per 1000 for 
probable autistic disorder and 5 per 1000 for probable 
Asperger syndrome, which is more than the reported 
rates across the world (16). Also, Nejatisafa (2003) 
performed the first preliminary study to investigate the 
frequency of ASDs in university students; while the 
scores were significantly higher for men than women, 
the frequency was 120 of 1000 adult participants (17). 
A study demonstrated the highest prevalence of ASDs 
for autistic disorder, then Asperger syndrome, and PDD-
NOS; also, it indicated that boys were 4 times more 
likely than girls to have autistic and Asperger disorders 
(18). The prevalence of autistic students is 0.366% 
among exceptional students (19). 
Etiology of ASDs 
With regard to etiology, the relationships between ASDs 
and some effective factors have been investigated. In 
a recent study, the theory of mind development was 
significantly affected by gender and IQ; thus, low-
functioning autistic children had the poorest performance 
in the theory of mind development compared with high-
functioning autistic children and the normal group 
(20). In the other study, IQ was an important factor in 
determining the visual memory of meaningless shapes 
in children and adolescents with ASDs; so a significant 
difference was observed in the visual memory of 
meaningless shapes between children and adolescents 
with ASDs and the normal group by entering the IQ 
effect, but the results were contrary by eliminating 
it. However, IQ variation did not correlate with facial 
memory in children with ASDs. There was no significant 
difference in facial memory between children with ASDs 
and the normal group in this study (21). 
In a clinical study, no significant correlation was 
observed between age, the diagnosis and severity of 
symptoms with gender in children with ASDs (22).  
Sasanfar (2010) investigated parental age and education 
level as risk factors and suggested that higher paternal 
age, but not maternal age, and higher education level 
increase the risk for autism. However, it seemed that 
parents with high education usually sought diagnostic 
and therapeutic services more than less educated parents 
(23).   
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In another Iranian study, no correlation was observed 
between autism and celiac diseases in autistic children 
compared with age- and sex-matched normal groups 
(24). 
The brain stem has a critical role in processing hearing 
inputs and has been investigated using an auditory brain 
stem response tool in children with slight and severe 
autism compared with a normal group. This research 
indicated brain stem abnormalities in severe autistic 
children, which can intensify autism symptoms (25). 
  
Diagnostic evaluation of ASDs 
Several studies have diagnosed abnormalities by 
quantitative electroencephalography (qEEG) analysis 
in children with ASDs in comparison with normal 
participants. Considering that the spectrogram showed 
more abnormalities in the left brain hemisphere and 
prefrontal lobe in children with ASDs compared with 
normal children, the relaxed eye-opened condition in the 
alpha band was the best condition under which 2 groups 
could be discriminated (26). 
 
Fig 1. International EEG electrode placement system (27)
Also, more abnormalities in the connectivity of temporal 
lobes with other lobes in the gamma frequency band 
have been based on coherence values in children with 
ASDs (28).
Autism Spectrum Disorders in Iran
Table 1: The spectrogram criteria values of the EEG for children with autism spectrum disorder
 (ASD) and control children for all electrodes in the alpha band (8–13 Hz) (28)
Electrodes ASD children (Mean±SD) Control children (Mean±SD)  P Value 
Fp1*  0.238±0.156                                   0.381±0.131                               0.018
Fp2  0.256±0.165                                  0.357±0.157                               0.122
F7*                       0.245±0.131                                   0.376±0.146                               0.021
F3** 0.197±0.076 0.442±0.103 0.000
Fz 0.237±0.106 0.309±0.175 0.192
F4 0.270±0.174 0.309±0.137 0.529
F8 0.300±0.198 0.337±0.118 0.583
T3** 0.254±0.136 0.405±0.130 0.007
C3* 0.251±0.156 0.401±0.121 0.013
Cz* 0.267±0.146 0.407±0.173 0.030
C4 0.291±0.182 0.310±0.190 0.796
T4 0.313±0.175 0.391±0.219 0.308
T5* 0.238±0.156 0.396±0.150 0.014
P3 0.300±0.154 0.411±0.133 0.063
Pz 0.310±0.196 0.395±0.147 0.231
P4 0.340±0.194 0.407±0.179 0.373
T6 0.319±0.170 0.388±0.123 0.258
O1 0.304±0.169 0.381±0.151 0.234
O2 0.308±0.161 0.293±0.163 0.821
** p<0.01 and * p<0.05
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Fig 2. Result of connectivity in 171 pairs of electrodes in frequency bands in the two groups control children and children 
with ASD disorders (p<0.05) shown with dotted lines and (p<0.01) shown with solid lines. a) gamma frequency band, b) alpha 
frequency band, c) beta frequency band (28)
Another research implicated the gamma frequency band as 
the best discriminant in children with Asperger compared 
with the normal group. Additionally, the prefrontal and 
right temporal lobes had more abnormalities based on 
the spectrogram, and the coherence values showed more 
abnormalities in the connectivity of the right temporal 
lobe as compared with the other lobes in the gamma 
frequency band in Asperger children (29). 
 
Fig 3. Results of connectivity in 171 pairs of electrodes that had significant differences in frequency bands. Significant differences 
with p<0.05 between control subjects and Asperger patients shown with dotted lines and with p<0.01 shown with solid lines. a) 
alpha, b) beta and c) gamma frequency band.(29)
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In another study, chaos theory was used to introduce 
a neural network model for EEG-based assessment of 
ASD with a precision of 90% (30). 
The differential diagnosis for social interaction and 
stereotyped behaviors was investigated between autistic 
and trainable mentally retarded children, which showed 
higher mean scores on qualitative damage to social 
interaction and stereotyped behaviors in autistic children 
compared with trainable mentally retarded children (31). 
Treatment of ASDs
Although there is no strong evidence of dopamine 
involvement in autism, neuroleptics have been used for a 
long time to decrease aggression, stereotypic behaviors, 
and impulsivity. Low-potency neuroleptics were soon 
abandoned, due to their cognitive and sedative side 
effects. Among high-potency neuroleptics, haloperidol 
has been studied most frequently. Several controlled 
studies showed its benefits over placebo among young 
children treated with 1 to 2 mg daily to improve 
attention and reduce hyperactivity, anger outbursts, and 
stereotypies (32, 33). However, problematic side effects, 
in the form of acute dystonic reactions, withdrawal 
dyskinesias, and tardive dyskinesias, were noted.
Typical neuroleptics have been replaced with atypical 
antipsychotics that combine dopamine (D2) and serotonin 
(5-HT2) receptor antagonist actions (32-35). Following 
several open-label studies that suggested the efficacy 
of risperidone, a 12-week, double-blind, placebo-
controlled trial was conducted with 31 adults (mean 
age 28 years) with autism and PDD-NOS. Significantly, 
at a mean dosage of 2.9 mg daily, more responders 
(57% vs 0%) were observed in the risperidone than in 
the placebo group, and improvements were noted in 
irritability, anxiety or nervousness, aggression, repetitive 
behaviors, and depression. There were no improvements 
on objective measurements of social behavior and 
language, suggesting that the drug targets nonspecific 
behavioral problems that are associated with autism (36, 
37). The drug was well tolerated.
More recently, a multicenter, 8-week, double-blind, 
placebo-controlled trial of risperidone (dosage range 
0.5 to 3.5 mg daily) was completed in 101 children with 
autism aged 5 to 17 years (mean age 8.8 years) who 
presented with clinical levels of tantrums, aggression, 
and self-injurious behavior. Significant benefits of the 
active medication were observed for the 2 primary 
outcome measures of reduced irritability scores (57% 
vs 14%) and a rating of “much improved” or “very 
much improved” on a Clinical Global Improvement 
(CGI) scale (69% vs 12%). Side effects, such as fatigue, 
drowsiness, increased appetite, and drooling, were more 
common in the risperidone group, as was a significantly 
higher weight gain (2.7 vs 0.8 kg).
Promising open-label studies have been conducted with 
olanzapine, quetiapine, clozapine, and ziprasidone; 
several randomized studies are currently underway. 
Atypical neuroleptics, therefore, appear to be promising 
agents that can be used to treat behavioral symptoms 
that often occur among autism patients. Yet, despite their 
good tolerability, these drugs are associated with some 
undesirable adverse effects, such as tachycardia in young 
children on risperidone and sedation for all atypicals, the 
most serious of which is substantial weight gain. There 
are no long-term studies on the drugs’ efficacy and 
tolerability (35-39).
Several pharmacological, behavioral, and social 
interventions for children with ASDs have been 
implemented in Iran. Akhondzadeh (2010) administered a 
double-blind, placebo-controlled trial to assess the effects 
of pentoxifylline added to risperidone in the treatment of 
autistic disorder, reducing scores for irritability, lethargy/
social withdrawal, stereotyped behavior, hyperactivity/
noncompliance, and inappropriate speech (40).
In another study, he examined the efficacy of 
piracetam added to risperidone in autistic disorder and 
determined that a combination of atypical antipsychotic 
medications and a glutamate agent, such as piracetam, 
has synergistic effects in the treatment of autism (41). 
Also, the combination of topiramate with risperidone 
reduced scores for irritability, stereotypic behavior, and 
hyperactivity/noncompliance compared with risperidone 
alone in autistic children (42). In another double-
blind, placebo-controlled trial, the 5-HT2 antagonist 
cyproheptadine plus haloperidol was evaluated in the 
treatment of autistic disorder. The results suggested that 
the combination of cyproheptadine with a conventional 
antipsychotic may be more effective than a conventional 
antipsychotic alone for autistic children (43). In a 
comparison of celecoxib added to risperidone with 
Autism Spectrum Disorders in Iran
6 Iran J Child Neurology   Vol5 No4 Autumn  2011
risperidone plus placebo, significant differences were 
observed between the 2 groups, showing reduced scores 
for irritability, lethargy, and stereotyped behavior in 
autistic children who took celecoxib plus risperidone 
(44). Ghanizadeh (2011) hypothesized that the glycine 
site on the N-methyl-D: -aspartic acid (NMDA) 
glutamate receptor can be tested as a new target for the 
treatment of autism (45). He also introduced neurotensin 
as a novel agent for autism (46). 
In a nonpharmacotherapeutic intervention, social stories 
as a social skill were evaluated in autistic children, and 
the results indicated that this intervention was effective 
in decreasing autistic behavior and improving social 
development in autistic children (47). In another study, 
the home-based Lovaas approach was performed 
for the treatment of autism, and the results showed 
that it was effective in improving social interaction, 
speech and language, and play and behavior skills in 
autistic children (48). Also, the effect of ABA (Applied 
Behavior Analysis) was demonstrated on autistic 
children, who had acquired significant improvements in 
suitable behaviors (49). In another study, 3 therapeutic 
interventions (drug, education, and combined therapy) 
were administered to autistic children, and the results 
showed that while risperidone therapy was effective 
primarily on stereotyped behavior and hyperactivity, 
education according to the Lovaas approach improved 
social communication and language development (50). 
The effectiveness of parent-child interaction therapy was 
investigated in 4 young children with high-functioning 
autism, and the results showed a decrease in their 
behavioral problems (51). 
Parental Studies
Because it seems that parents of children with ASDs 
experience stresses, such as stigma, blame, and 
insufficient social support in developing countries (52, 
53), several studies have been performed to investigate 
parental problems, especially those of mothers, in Iran. 
A scientific report indicated a significant difference in 
parenting stress and coping strategy (emotion-focused 
and problem-focused) variables between mothers with 
autistic children and mothers who had normal children; 
also, a significant correlation was observed between 
stress levels and emotion-focused coping strategies 
in mothers with autistic children (54). Another study 
investigated personality characteristics and attachment 
style in mothers with autistic children in comparison 
with mothers who had normal children and showed a 
significant difference in neuroticism versus emotional 
stability but not in other characteristics; also, no 
significant difference was observed in attachment style 
between the 2 groups. Based on these results, while 
mothers with autistic children could be in the neurotic 
group, mothers with normal children were almost always 
in the emotionally stable group (55). The correlation 
between personality characteristics and coping strategies 
was studied in parents who had children with ASDs and 
indicated no significant difference in coping strategies 
between fathers and mothers of children with ASDs; 
however, original thinking, sociability, and vigor 
characteristics differed significantly between them (56). 
Samadi (2009) evaluated the general health and stress 
levels in parents who had children with ASDs and 
showed that mothers had significantly higher scores 
than fathers (57). In another study, parental stress was 
compared in mothers of autistic children with mothers 
who had normal children, and the results indicated higher 
parental stress scores for mothers of autistic children 
(58). The results of another study showed that 27.5% of 
mothers with autistic children had mental disease, and a 
significant correlation was observed between insufficient 
coping strategies and mental health (59).  
Some interventions were performed to reduce 
mental problems in mothers with autistic children. A 
preliminary investigation showed that the symptoms of 
stress, depression, and anxiety in mothers with autistic 
children were relatively reduced by guided imagery 
via music (60). In another study, group counseling was 
administered to a group of mothers with autistic children, 
and the results indicated significant differences in family 
performance and marital satisfaction scores in mothers 
who had received group counseling compared with the 
control group (61). 
In conclusion, It appears that autism spectrum 
disorders are unknown in developing countries, and 
parents who have children with ASDs suffer from a 
lack of social support. Although several studies on 
ASDs have been performed recently in Iran, they are not 
sufficient, especially with regard to ASD epidemiology. 
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Because of the essential role of cultural factors bettering 
increasing our understanding and treatment of ASDs, 
more comprehensive research on the prevalence, 
etiology, diagnosis, and treatment of ASDs should be 
performed in Iran. 
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